Clinical trial Recruiting at 3 sites Interventional Ages 5 and up

Understanding the genetic causes of language development disorders in children

Official title: BASES MOLECULAIRES DU DEVELOPPEMENT DU LANGAGE ORAL ET DES TROUBLES SPECIFIQUES ASSOCIES

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT06660108 · Data updated 2026-11-12

This study is trying to find out the genetic reasons behind language development disorders in children to help understand and treat them better.

Quick facts

Study typeInterventional
Ages5 Years and up
SexAll
Enrollment50 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations3 sites (Corbeil-Essonnes and 2 other locations)
StatusRecruiting
StartedMarch 25, 2025
Main results expectedMarch 25, 2027
Study endsMarch 25, 2028
Registry record updatedJuly 7, 2026
Trial IDNCT06660108 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children over five years old with a formal diagnosis of severe and isolated DLD who have received appropriate speech therapy.

Probably not a fit

Patients with cognitive impairments or co-occurring disorders such as autism spectrum disorder may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on children diagnosed with Developmental Language Disorder (DLD) to investigate the genetic underpinnings of this condition. By utilizing high-throughput sequencing, the research aims to distinguish sub-groups of children with language difficulties that are not associated with other known disorders. Eligible participants will undergo a blood draw for genetic analysis, and the study seeks to improve the understanding of DLD by examining a more homogeneous cohort. The goal is to clarify the clinical heterogeneity of language disorders and enhance future research and clinical practices.

Why it matters

Potential benefit: If successful, this study could lead to better diagnostic tools and targeted interventions for children with Developmental Language Disorder.

How similar studies have gone: While there have been successful studies focusing on genetic causes of other language disorders, this specific approach to DLD is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patients

Inclusion Criteria:

* Eligible families included at least one child over five years old with a formal diagnosis of severe and isolated DLD according to Phase 2 CATALISE criteria . Patients have undergone age-appropriate speech, language and reading evaluations by a speech-language physician and cognitive evaluations by a neuropsychologist, as well as evaluation by a pediatric neurologist to identify co-occurring developmental disorders (ADHD, ASD…) and a medical geneticist for known genetic disorders and genetic testing recommendations. All children included received appropriate speech therapy for at least one year, with a progress report indicating the persistence of language difficulties.

Exclusion Criteria:

* Cognitive impairment with non-verbal intellectual quotient (IQ) below 2 SD assessed with the Wechsler Preschool and Primary Scale of Intelligence (WPPSI), or the Wechsler Intelligence Scale for Children (WISC-IV or V) according to the age-appropriateness, ASD, moderate to severe hearing loss, orofacial structural abnormalities, known neurological or genetic disorders at the initial assessment. None of the patients met the diagnostic criteria for CAS according to the ASHA (American Speech-Language-Hearing Association, 2007. Childhood apraxia of speech www.asha.org/policy).

Where it's running

  • Hopital Sud Francilien
    Corbeil-Essonnes, France
    Recruiting
  • Raymond Poincaré- Garches
    Garches, France
    Recruiting
  • Hopital Necker
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.